UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bone health in cancer: ESMO Clinical Practice Guidelines

Annals of oncology, 2020-12, Vol.31 (12), p.1650-1663

2020

Volltextzugriff (PDF)

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

Annals of oncology, 2012-05, Vol.23 (5), p.1341-1347

2012

Volltextzugriff (PDF)

Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis

Bone (New York, N.Y.), 2018-03, Vol.108, p.79-88

2018

Volltextzugriff (PDF)

Anti-vascular endothelial growth factor antibody monotherapy causes destructive advanced periodontitis in rice rats (Oryzomys palustris)

Bone (New York, N.Y.), 2020-01, Vol.130, p.115141-115141, Article 115141

2020

Volltextzugriff (PDF)

Making a Case for Defining Osteonecrosis of the Jaw

Journal of dental research, 2011-04, Vol.90 (4), p.399-401

Van Poznak, C.

2011

Volltextzugriff (PDF)

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations

Journal of bone oncology, 2021-08, Vol.29, p.100375-100375, Article 100375

2021

Volltextzugriff (PDF)

Cancer-associated bone disease

Osteoporosis international, 2013-12, Vol.24 (12), p.2929-2953

2013

Volltextzugriff (PDF)

The heat shock protein 90 chaperone complex: an evolving therapeutic target

Current cancer drug targets, 2008-09, Vol.8 (6), p.522-535

2008

Volltextzugriff (PDF)

Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022

Annals of oncology, 2024-11, Vol.35 (11), p.993-1002

2024

Volltextzugriff (PDF)

Use of bone-modifying agents (BMA) and osteonecrosis of the jaw (ONJ) among older patients with metastatic breast cancer (BC)

Annals of oncology, 2018-10, Vol.29, p.viii115-viii115

2018

Volltextzugriff (PDF)

New therapies for cancer induced bone disease: Clinical perspective

Bone (New York, N.Y.), 2011-01, Vol.48 (1), p.S10-S10

Van Poznak, C

2011

Volltextzugriff (PDF)

Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma

Bone (New York, N.Y.), 2011-01, Vol.48 (1), p.S18-S19

2011

Volltextzugriff (PDF)

Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial

Breast cancer research and treatment, 2001-04, Vol.66 (3), p.239-248

2001

Volltextzugriff (PDF)

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours

Journal of clinical pathology, 2006-01, Vol.59 (1), p.56-63

2006

Volltextzugriff (PDF)

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

The Lancet (British edition), 2015-10, Vol.386 (10001), p.1353-1361

2015

Volltextzugriff (PDF)

182P Radium-223 (223Ra) in combination with exemestane and everolimus (EXE-EVE) in patients (pts) with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC) with bone metastases: A phase II study

Annals of oncology, 2022-05, Vol.33, p.S211-S212

2022

Volltextzugriff (PDF)

Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis

Supportive care in cancer, 2016-11, Vol.24 (11), p.4815-4824

2016

Volltextzugriff (PDF)

349PUse of bone-modifying agents (BMA) and osteonecrosis of the jaw (ONJ) among older patients with metastatic breast cancer (BC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

Journal of bone and mineral research, 2007-10, Vol.22 (10), p.1479-1491

2007

Volltextzugriff (PDF)

P146 - Outcomes associates with the use of bone-modifying agents (BMA) among older patients with metastatic breast cancer (BC)

Breast (Edinburgh), 2019-03, Vol.44, p.S65-S65

2019

Volltextzugriff (PDF)

Outcomes associates with the use of bone-modifying agents (BMA) among older patients with metastatic breast cancer (BC)

Breast (Edinburgh), 2019-03, Vol.44, p.S65

2019

Volltextzugriff (PDF)

Periodontal Health in Women With Early‐Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study

Journal of periodontology (1970), 2015-07, Vol.86 (7), p.906-916

2015

Volltextzugriff (PDF)

Pregnancy after bone marrow transplantation

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1978-1985

1998

Volltextzugriff (PDF)

Abstract OT3-05-01: TBCRC 039: Phase II study of combination ruxolitinib (INCB018424) with preoperative chemotherapy for triple negative inflammatory breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT3-05-01-OT3-05-01

2018

Volltextzugriff (PDF)

Abstract OT1-02-03: TBCRC 044: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT1-02-03-OT1-02-03

2018

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(117)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Humans
(52)
Oncology
(48)
Female
(40)
Breast Neoplasms - Drug Therapy
(23)
Middle Aged
(21)
Breast Neoplasms - Pathology
(20)
Breast Cancer
(19)
Adult
(15)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Aged
(11)
Treatment Outcome
(11)
Bone Neoplasms - Secondary
(10)
Chemotherapy
(10)
Antineoplastic Agents - Therapeutic Use
(8)
Cancer Research
(8)
Diphosphonates - Adverse Effects
(8)
Diphosphonates - Therapeutic Use
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bone health in cancer: ESMO Clinical Practice Guidelines

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis

Anti-vascular endothelial growth factor antibody monotherapy causes destructive advanced periodontitis in rice rats (Oryzomys palustris)

Making a Case for Defining Osteonecrosis of the Jaw

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations

Cancer-associated bone disease

The heat shock protein 90 chaperone complex: an evolving therapeutic target

Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022

Use of bone-modifying agents (BMA) and osteonecrosis of the jaw (ONJ) among older patients with metastatic breast cancer (BC)

New therapies for cancer induced bone disease: Clinical perspective

Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma

Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

182P Radium-223 (223Ra) in combination with exemestane and everolimus (EXE-EVE) in patients (pts) with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC) with bone metastases: A phase II study

Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis

349PUse of bone-modifying agents (BMA) and osteonecrosis of the jaw (ONJ) among older patients with metastatic breast cancer (BC)

Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

P146 - Outcomes associates with the use of bone-modifying agents (BMA) among older patients with metastatic breast cancer (BC)

Outcomes associates with the use of bone-modifying agents (BMA) among older patients with metastatic breast cancer (BC)

Periodontal Health in Women With Early‐Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study

Pregnancy after bone marrow transplantation

Abstract OT3-05-01: TBCRC 039: Phase II study of combination ruxolitinib (INCB018424) with preoperative chemotherapy for triple negative inflammatory breast cancer

Abstract OT1-02-03: TBCRC 044: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease

Suchergebnisse filtern